Transcend Capital Advisors, LLC Astrazeneca PLC Transaction History
Transcend Capital Advisors, LLC
- $1.35 Billion
- Q2 2024
A detailed history of Transcend Capital Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 77,912 shares of AZN stock, worth $6.01 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
77,912
Previous 21,515
262.13%
Holding current value
$6.01 Million
Previous $1.46 Million
317.02%
% of portfolio
0.45%
Previous 0.12%
Shares
13 transactions
Others Institutions Holding AZN
# of Institutions
1,248Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.73 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.79 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.31 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.66 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.33 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $239B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...